Target intelligence / Profile preview

Neuroblastoma amplified sequence pseudogene

Molecular classification: Other (pseudogene, not a receptor, enzyme, transporter, etc.)

Overview

The "neuroblastoma amplified sequence pseudogene" (ENSG00000248715) is a *pseudogene*, meaning it resembles a protein-coding gene but does not code for a functional protein. It is related by sequence to the *Neuroblastoma amplified sequence* (NBAS) gene, but, as a pseudogene, it is generally considered non-functional and is not involved in normal biological processes, disease mechanisms, or therapeutic interventions. There is no evidence indicating this pseudogene has any established biological function, disease association, or relevance as a drug target.

Other names: NBAS pseudogeneneuroblastoma amplified sequence pseudogene

Beyond the preview

Go deeper on Neuroblastoma amplified sequence pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroblastoma amplified sequence pseudogene.

Explore the full profile